Galectin-3 in Patients With Paroxysmal and Persistent Atrial Fibrillation and Metabolic Syndrome
von Albertini AE. L. ZaslavskayaA.V. Soboleva SobolevaE. I. BaranovaO.V. Listopad ListopadS. E. NifontovA.O. Соnrady СоnradyЕ. V. Shlyakhto
Abstract
Marker of myocardial fibrosis serum galectin 3 in patients with atrial fibrillation and metabolic syndrome is higher than in patients with the metabolic syndrome, without this arrhythmia and higher than in healthy controls. In patients with persistent AF level of galectin 3 was higher than in patients with paroxysmal AF.
Metrics
Citation History
Topics
Related Documents
PW010 Plasma Galectin-3 Elevated in Patients With Paroxysmal and Persistent Atrial Fibrillation
Xiao Y. WuRong BaiNian LiuSong Nan LiSong WenXin DuJianzeng DongChang Sheng
GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
V. A. LoninА. В. СоболеваO. V. ListopadS. E. NifontovE. BazhenovaElena VasilievaE. I. BaranovaЕ. V. Shlyakhto
Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation
Qianhui WangLi XuYing DongYuan FuYuxia PanQianran LuanYujing LiuZheng LiuXinchun YangMulei ChenYuanfeng Gao
PLASMA GALECTIN-3 ELEVATED IN PATIENTS WITH LONE PERSISTENT AND PAROXYSMAL ATRIAL FIBRILLATION AND ASSOCIATED WITH LEFT ATRIAL ENLARGEMENT
Xiaoyan WuRong BaiSongnan WenXin DuJianzeng DongChangsheng MaSongnan Li
sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation
Ruth Saez‐MaletaAna Merino‐MerinoSimón Gundín‐MenéndezRicardo Salgado‐ArandaDaniel AlKassam-MartinezVirginia Pascual‐TejerinaJavier Martín‐GonzálezF. FernandezJose-Ángel Pérez-Rivera